Stephen Strittmatter on a first-in-human trial for treating

The Lancet Neurology in conversation with

Stephen Strittmatter on a first-in-human trial for treating chronic cervical spinal cord injury

Listen now

Description

Stephen Strittmatter (Yale School of Medicine, CT, USA) discusses his first-in-human and randomised trial of a soluble Nogo-receptor-Fc decoy in patients with chronic cervical spinal cord injury. The Article is published in the August issue of The Lancet Neurology. Read the full article: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00215-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_laneur Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

More Episodes

See all »

Sanjay Sisodiya on climate change and brain health

Sanjay Sisodiya joins The Lancet Neurology to discuss the potential effects of climate change on brain health. The Personal View is published in the June issue of The Lancet Neurology.Continue this conversation on social!Follow us today...

Published 05/15/24

The Lancet Neurology in conversation with

Published 05/15/24

Jacqueline French and Jacob Pellinen on the diagnosis of epilepsy

Jacqueline French and Jacob Pellinen join Senior Editor Sarah Passey to discuss recent progress made in the diagnosis of epilepsy and challenges that remain. Their Review on this topic is published in the May issue of The Lancet Neurology. Read the full...

Published 04/15/24